Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO). Phase I.

MLA

“Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO). Phase I.” Clinical Trials Week, July 2024, p. 1253. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=178635583&authtype=sso&custid=ns315887.

APA

Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO). Phase I. (2024). Clinical Trials Week, 1253.

Chicago

“Migraine Attack Treatment Response Molecular and Clinical BiOmarkers (MAMBO). Phase I.” 2024. Clinical Trials Week, July, 1253. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edb&AN=178635583&authtype=sso&custid=ns315887.